spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online December 31, 2008
doi: 10.1242/10.1242/jcs.029108


Journal of Cell Science 122, 278-288 (2009)
Published by The Company of Biologists 2009
This Article
Right arrow Summary Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JCS
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Margadant, C.
Right arrow Articles by Sonnenberg, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Margadant, C.
Right arrow Articles by Sonnenberg, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Integrin {alpha}3β1 inhibits directional migration and wound re-epithelialization in the skin

Coert Margadant, Karine Raymond*, Maaike Kreft, Norman Sachs, Hans Janssen and Arnoud Sonnenberg{ddagger}

Division of Cell Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands


Figure 1
View larger version (89K):
[in this window]
[in a new window]

 
Fig. 1. Skin phenotype of Itga3flox/flox; K14-Cre mice. (A) Cryosections from back skin of neonatal Itga3flox/flox and Itga3flox/flox; K14-Cre mice were stained with antibodies directed against the {alpha}3 subunit and Ln-332 (top row). Scale bar: 100 µm. H&E-stained section showing the structure of the epidermis and the dermis from back skin of 4-month-old Itga3flox/flox and Itga3flox/flox; K14-Cre mice are shown in second row from top. Scale bar, 200 µm. Bottom two rows are EM images and schematic representations of back skin of 1-year-old Itga3flox/flox and Itga3flox/flox; K14-Cre mice, showing the basement membrane and hemidesmosomes (indicated by arrowheads). Scale bar: 200 nm. (B) H&E staining of back skin of a 1-year old Itga3flox/flox; K14-Cre mouse (top). Arrowheads indicate microblisters at the DEJ. Scale bar: 500 µm. Lower panels are cryosections of a region containing microblisters stained with antibodies against Ln-332 and β4. Arrowheads indicate blisters. Scale bar: 50 µm. (C) Ultrastructural analysis and schematic representation of back skin of a 1-year-old Itga3flox/flox; K14-Cre mouse, showing basement membrane duplication. The two basement membranes are marked with solid and dashed lines, and collagen fibers extending throughout the two basement membranes are indicated. Scale bar: 200 nm. (D) Regions of inflammation in a 4-month-old Itga3flox/flox; K14-Cre mouse are denoted by arrows. Back skin sections were stained with an antibody against CD3. Arrows indicate infiltrated lymphocytes. Scale bar in the third panel: 200 nm. (E) Alopecia in a 1-year-old Itga3flox/flox; K5-Cre mouse (right), compared with an Itga3flox/flox mouse of the same age. BM, basement membrane; Col, collagen; D, dermis; E, epidermis.

 

Figure 2
View larger version (93K):
[in this window]
[in a new window]

 
Fig. 2. Deletion of integrin {alpha}3 in the epidermis does not inhibit keratinocyte differentiation. Skin cryosections from neonatal Itga3flox/flox and Itga3flox/flox; K14-Cre mice were stained with antibodies directed against keratin 14, filaggrin or involucrin, and counterstained with Ln-332 and DAPI to visualize the basement membrane and nuclei, respectively. Scale bar: 50 µm.

 

Figure 3
View larger version (52K):
[in this window]
[in a new window]

 
Fig. 3. Wound closure is accelerated in the absence of {alpha}3β1 integrin. Full-thickness wounds were generated on either side of the dorsal midline in Itga3flox/flox or Itga3flox/flox; K14-Cre mice, and excised 3 or 7 days after injury. (A) Schematic representation of a wound. D, dermis; E, epidermis; Es, eschar; F, fat tissue; G, granulation tissue. (B) H&E-stained sections depicting wound closure 7 days after wounding in Itga3flox/flox (top) and Itga3flox/flox; K14-Cre mice (bottom). Arrows indicate the edges of the migrating epithelium. The number of closed wounds after 7 days of migration is represented in the bar graph. Depicted are the means ± s.e.m. of at least 40 wounds pooled from four independent experiments (*P<0.05). Scale bar, 500 µm. (C) The distance covered by the migrating epidermis (indicated by the dotted line) was quantified 3 days after wounding in Itga3flox/flox (top) and Itga3flox/flox; K14-Cre mice (bottom). The graph indicates the means ± s.e.m. of at least 35 wounds pooled from three experiments (*P<0.05). Scale bar, 250 µm. (D) Proliferation in the re-epithelializing wounds was assessed by injecting BrdU 2 or 4 days after wounding, and determining the ratio of BrdU+ cells over the total number of cells using ImageJ. Depicted are the means ± s.e.m. of at least 30 images. Scale bar: 150 µm.

 

Figure 4
View larger version (37K):
[in this window]
[in a new window]

 
Fig. 4. In vitro adhesion to Ln-332 is rescued by {alpha}6 integrins in the absence of {alpha}3β1 integrin. Keratinocytes were isolated from newborn Itga3flox/flox mice and designated MK{alpha}3+. MK{alpha}3 cells were then obtained by in vitro deletion of Itga3. (A) Immunoblot depicting the expression of {alpha}3 in MK{alpha}3+ and MK{alpha}3 cells. Murine mammary cell line Rac-11P and murine fibroblast cell line NIH3T3 were included as a positive and negative control, respectively. (B) Cell surface expression of integrin subunits {alpha}5, {alpha}2, {alpha}6, {alpha}v, β4 and β1 in MK{alpha}3+ and MK{alpha}3 was determined by FACS analysis. The negative control (only secondary antibody) is indicated by the black graph. (C) MK{alpha}3+ and MK{alpha}3 cells were seeded onto Col-1 or Ln-332 in K-SFM without supplements in the absence or the presence of the {alpha}6-blocking antibody GoH3 (10 µg/ml). After 30 minutes, non-adherent cells were washed away. Values shown represent the average percentages of adherent cells from three experiments performed in triplicate (*P<0.05, ***P<0.0005). (D) Immunoprecipitation of integrin subunits {alpha}6 and β1 was performed on lysates of MK{alpha}3+ and MK{alpha}3 cells. The precipitates were resolved by SDS-PAGE, and analyzed for the presence of the integrins β1 and β4, and the light chains (L) of {alpha}3 and {alpha}6 by western blotting.

 

Figure 5
View larger version (58K):
[in this window]
[in a new window]

 
Fig. 5. The integrin {alpha}6β1 mediates cell spreading on endogenous Ln-332 when {alpha}3β1 is absent. MK{alpha}3+ and MK{alpha}3 cells were seeded on Ln-332 (A) or Col-1 (B), allowed to spread, and then incubated with {alpha}6-blocking antibody GoH3 (10 µg/ml). After 3 hours, the number of spread cells was scored and expressed as a percentage of the total number of cells. In each independent experiment, approximately 500 cells were counted for each condition. The graphs depict the averages of three experiments (*P<0.05, ***P<0.0005). Scale bar: 50 µm.

 

Figure 6
View larger version (42K):
[in this window]
[in a new window]

 
Fig. 6. Ln-332 synthesis and deposition are not affected by the deletion of the integrin {alpha}3 subunit. (A) MK{alpha}3+ and MK{alpha}3 cells were seeded on Col-I and then detached with EDTA at the indicated time points after which the ECM was dissolved in sample buffer, subjected to SDS-PAGE, and the {gamma}2 chain of Ln-332 was detected by western blotting. (B) Immunofluorescence images demonstrating patches of deposited Ln-332 in spread MK{alpha}3+ cells (left panel) and MK{alpha}3 cells (right panel). Scale bar: 10 µm. (C) Low-magnification immunofluorescence images demonstrating Ln-332 trails left behind by MK{alpha}3+ cells (left), and MK{alpha}3 cells (right) migrating over Col-I. Scale bar: 10 µm.

 

Figure 7
View larger version (36K):
[in this window]
[in a new window]

 
Fig. 7. Loss of {alpha}3 enhances directionality and velocity of keratinocyte migration. (A) Confluent MK{alpha}3+ and MK{alpha}3 cells were deprived of growth factors, incubated for 2 hours with mitomycin C (10 µg/ml), and scratched with the tip of a pipette prior to EGF stimulation. The black bars indicate the wound edges at t=0. Scale bar: 100 µm. Wound areas were measured using ImageJ, and the ratio of the wound area after overnight migration over the wound area at t=0 was calculated and expressed in the bar graph. Values shown represent the means ± s.e.m. of three independent experiments (***P<0.0005). (B) EGF-induced phosphorylation of ERK1/2 was monitored by western blotting in lysates of MK{alpha}3+ and MK{alpha}3 cells that were deprived of growth factors prior to EGF stimulation for the indicated time points. (C) Cells were sparsely seeded on Col-I and monitored in time-lapse recordings for 16 hours. An image was captured every 5 minutes. Cell tracks were then determined using ImageJ. The migration plots indicate tracks from ten individual cells from four independent experiments. To quantify the average velocity and directionality (D/T ratio), data from four independent experiments were pooled. The graphs represent the means ± s.e.m. from ~50 cells (*P<0.05, **P<0.005, ***P<0.0005). To determine whether polarization was stable, cells were sparsely seeded on Col-I and monitored by time-lapse recordings. An image was captured every 5 minutes. A cell was considered stably polarized when maintaining a leading lamellipodium for 1 hour. The number of polarized cells was counted and expressed as a percentage of the total number of cells. The graph shows the means ± s.e.m. from 250 cells pooled from four independent experiments (*P<0.05). (D) Cells were sparsely seeded on Ln-332 or Col-I, serum-starved, and then stimulated with 5 ng/ml EGF at the indicated time points. An image was captured every 5 minutes. Cell tracks were determined using Matlab (Mathworks), and average velocity was plotted over time. The graphs depict the average velocity of ~50 cells from a representative experiment.

 

Figure 8
View larger version (41K):
[in this window]
[in a new window]

 
Fig. 8. The phenotype of MK{alpha}3 cells is reversed by reconstitution with human {alpha}3A. (A) MK{alpha}3 cells were transduced with the cDNA encoding human {alpha}3A, and cell surface expression was verified by FACS analysis using monoclonal antibody J143 against human {alpha}3. Negative control (secondary antibody only) is indicated by thin black line. (B) MK{alpha}3R cells were seeded on Ln-332 (left panel) or Col-I (right panel), allowed to spread, and then incubated for 3 hours with GoH3 (10 µg/ml). Scale bar: 20 µm. (C) The number of spread cells was scored and expressed as a percentage of the total number of cells. In each independent experiment, approximately 500 cells per condition were counted. The graphs depict the averages of three experiments (***P<0.0005). (D) Lysates of MK{alpha}3+, MK{alpha}3 and MK{alpha}3R cells were analyzed by SDS-PAGE, and expression of integrin {alpha}3 was determined by western blotting using mAb 29A3 recognizing both human and murine {alpha}3 (L, light chain). Confluent MK{alpha}3+, MK{alpha}3, and MK{alpha}3R cells were deprived of growth factors, incubated for 2 hours with mitomycin C (10 µg/ml), and scratched with the tip of a pipette prior to EGF stimulation. Wound areas were determined using Image J, and the ratio of the wound area after overnight migration over the wound area at t=0 was calculated and expressed in a bar graph. Values shown represent the means ± s.e.m. of three independent experiments (*P<0.05, ***P<0.0005).

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




© The Company of Biologists Ltd 2009